avenuetx.com (ATXI) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Avenue Therapeutics (ATXI) miya buzilishlarini davolashga bo'lgan talab iqtisodiy sharoitlardan qat'i nazar barqaror qoladigan nostsikl sektorida faoliyat yuritadi. GURU.Markets platformasidagi ushbu narxlar grafigi 0.00 ko'rsatkichini aks ettiradi. Bozor kapitalizatsiyasi shoshilinch yordam vositalarini ishlab chiqish va hukumat shartnomalariga asoslangan, sinovlarning uzluksizligi esa optimallashtirilgan komponentlar yetkazib berish tizimi va tashqi laboratoriyalar tarmog'i bilan kafolatlanadi.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_ATXI_-_Avenue-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "ATXI - Avenue Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 29.03.2025 oraligʻida | 👁️GURU.Markets👁️")
Avenue Therapeutics (ATXI) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Avenue Therapeutics|ATXI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati avenuetx.com|ATXI - Kompaniyaning umumiy qarzi|Qarzning balans kapitallashuviga nisbati Avenue Therapeutics, Inc.|ATXI - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Avenue Therapeutics|Shoshilinch likvidlik koeffitsiyenti avenuetx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Avenue Therapeutics Inc.
Ushbu koeffitsient uzoq muddatli majburiyatlarning kapitalga nisbatini o'lchab, Avenue Therapeutics kompaniyasining moliyaviy leveraj darajasini aniqlaydi. Cheklangan resurslarga ega bo'lgan Avenue Therapeutics uchun ushbu muvozanat FDA bilan o'zaro aloqalarda juda muhimdir. Uzoq muddatli qarzning kapitalga nisbatini tahlil qilish qarz moliyalashtirishining yashirin xatarlarini aniqlashga yordam beradi. Leverajning ortishi likvidlik yetishmovchiligi signalini berishi mumkin. Investorlar ushbu tendentsiyani biznes barqarorligining ko'rsatkichi sifatida baholashlari lozim.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BHVN (Biohaven)|Uzoq muddatli qarzning o'z kapitaliga nisbati AMLX (Amylyx Pharmaceuticals Inc)|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Praxis Corp (PRAX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|CBLL (ceribell.com) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alector (ALEC) - Uzoq muddatli qarzning kapitalga nisbati|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Omeros Corp. OMER|Uzoq muddatli qarzning o'z kapitaliga nisbati NGNE (Neurogene Inc.)|ACIU (acimmune.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati NMRA (Neumora)|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati cogrx.com (CGTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|SAVA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ASRT|Uzoq muddatli qarzning kapitalga nisbati coyatherapeutics.com (COYA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vistagen VTGN|OVID (Ovid Therapeutics Inc) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati CervoMed, Inc.|ATHE (alteritytherapeutics.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Clene (CLNN) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati PEPG|JUNS (jupiterneurosciences.com) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati RLMD|Uzoq muddatli qarzdorlikning kapitalga nisbati Annovis Bio Inc|Uzoq muddatli qarzning kapitalga nisbati GRCE (Grace Therapeutics)|AIFF - Uzoq muddatli qarzning o'z kapitaliga nisbati|KLTO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NeuroSense Therapeutics NRSN|RVPH: Uzoq muddatli qarzning kapitalga nisbati|MetaVia (MTVA) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NRXS|HSDT (Helius Medical Technologies Inc.) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati PASG (Passage Bio, Inc.)|bionomics.com.au - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati NERV (Minerva Neurosciences, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati Athira Pharma Inc (ATHA)|ADXN - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALZN (Alzamend Neuro, Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|CYCN: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Protagenic Therapeutics, Inc. (PTIX)|Uzoq muddatli qarzning o'z kapitaliga nisbati KTTA|Uzoq muddatli qarzning kapitalga nisbati Cortigent Medical|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|CARA (Cara Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati|MRNS (Marinus) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGN (NKGen Biotech Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|Trevena Inc. - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Anew Medical Inc. WENA|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati